2018年9月13日星期四

The future of peptide‐based drugs

The future of peptide‐based drugs

DJ CraikDP Fairlie, S Liras… - Chemical biology & drug …, 2013 - Wiley Online Library
The suite of currently used drugs can be divided into two categories–traditional 'small
molecule'drugs with typical molecular weights of< 500 Da but with oral bioavailability, and
much larger 'biologics' typically> 5000 Da that are not orally bioavailable and need to be …

没有评论:

发表评论